240 related articles for article (PubMed ID: 17326126)
1. Clinicopathologic features of poorly differentiated hepatocellular carcinoma.
Oishi K; Itamoto T; Amano H; Fukuda S; Ohdan H; Tashiro H; Shimamoto F; Asahara T
J Surg Oncol; 2007 Mar; 95(4):311-6. PubMed ID: 17326126
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.
Fukuda S; Itamoto T; Nakahara H; Kohashi T; Ohdan H; Hino H; Ochi M; Tashiro H; Asahara T
Hepatogastroenterology; 2005; 52(64):1163-7. PubMed ID: 16001653
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of early hepatocellular carcinoma after hepatic resection.
Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.
Ariizumi S; Takasaki K; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S
Hepatogastroenterology; 2004; 51(56):500-4. PubMed ID: 15086191
[TBL] [Abstract][Full Text] [Related]
7. Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.
Imai K; Beppu T; Nakayama Y; Ishiko T; Horino K; Komori H; Masuda T; Hayashi H; Okabe H; Baba Y; Watanabe M; Takamori H; Awai K; Yamashita Y; Baba H
J Surg Oncol; 2009 Aug; 100(2):121-6. PubMed ID: 19402077
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
Shimada M; Hasegawa H; Gion T; Shirabe K; Taguchi K; Takenaka K; Tanaka S; Sugimachi K
Hepatogastroenterology; 1999; 46(28):2469-75. PubMed ID: 10522022
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of major hepatectomy for large hepatocellular carcinoma.
Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
[TBL] [Abstract][Full Text] [Related]
10. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.
Okusaka T; Okada S; Ueno H; Ikeda M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Fukushima N; Sakamoto M
Cancer; 2002 Nov; 95(9):1931-7. PubMed ID: 12404287
[TBL] [Abstract][Full Text] [Related]
11. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
12. Relationship between period of survival and clinicopathological characteristics in patients with hepatocellular carcinoma who underwent hepatectomy.
Nanashima A; Abo T; Tobinaga S; Kunizaki M; Hidaka S; Nonaka T; Miuma S; Taura N; Miyaaki H; Nakashima M; Sawai T; Nakao K; Nagayasu T
Hepatogastroenterology; 2010; 57(99-100):540-6. PubMed ID: 20698224
[TBL] [Abstract][Full Text] [Related]
13. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
[TBL] [Abstract][Full Text] [Related]
14. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features and surgical treatment of large hepatocellular carcinoma].
Chen JS; Wang Q; Liang LJ; Chen XL; Li DM
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1097-9. PubMed ID: 20646425
[TBL] [Abstract][Full Text] [Related]
16. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of mrp gene in primary hepatocellular carcinoma.
Wang BL; Chen XP; Zhai SP; Chen DF
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):397-403. PubMed ID: 14599947
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Cillo U; Navaglia F; Vitale A; Molari A; Basso D; Bassanello M; Brolese A; Zanus G; Montin U; D'Amico F; Ciarleglio FA; Carraro A; Bridda A; Burra P; Carraro P; Plebani M; D'Amico DF
Clin Chim Acta; 2004 Sep; 347(1-2):129-38. PubMed ID: 15313150
[TBL] [Abstract][Full Text] [Related]
19. Adaptation of hepatectomy for huge hepatocellular carcinoma.
Taniai N; Yoshida H; Tajiri T
J Hepatobiliary Pancreat Surg; 2008; 15(4):410-6. PubMed ID: 18670843
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous microwave coagulation therapy for hepatocellular carcinoma].
Itamoto T; Asahara T; Kohashi T; Katayama S; Fukuda S; Nakatani T; Fukuda T; Yano M; Nakahara H; Okamoto Y; Katayama K; Dohi K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1841-4. PubMed ID: 10560408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
